May 23, 2023 by James HalleyWhy Shares of Akebia Therapeutics Were Up TuesdayAn approval in the U.K. for Akebia's symptomatic anemia therapy boosted the stock.
May 23, 2023 by James HalleyBuying These 2 Stocks Is a Good Way to Hedge Against a Market CrashBoth companies have produced consistent revenue growth and predictable profitability.
May 22, 2023 by James HalleyWhy Shares of Rain Oncology Are Plummeting TodayThe company released disappointing top-line results for its lead oncology therapy.
May 22, 2023 by James HalleyWhy Shares of Krystal Biotech Are Rising MondayThe company is moving quickly to market its newly approved therapy.
May 22, 2023 by James HalleyWhy Shares of VectivBio Holding Are Up TodayA buyout offer by Ironwood Pharmaceuticals lifted the clinical-stage biotech's stock.
May 21, 2023 by James Halley3 Things About Teladoc That Smart Investors KnowTeladoc Health's shares have plummeted over the past couple of years.
May 19, 2023 by James HalleyWhy Shares of Guardant Health Jumped This WeekThe cancer diagnostic company saw its shares take a big jump for the second straight week.
May 19, 2023 by James HalleyWhy Shares of Nutex Health Jumped on FridayThis week's bounce back is a correction to an overreaction after the company's first-quarter earnings report.
May 19, 2023 by James HalleyWhy Shares of Catalent Were Up FridayThe company announced it was delaying its third-quarter report a second time.
May 19, 2023 by James Halley2 Healthcare Stocks You Can Buy and Hold for the Next DecadeThese two solid companies should be buoyed by recent tailwinds.
May 18, 2023 by James HalleyWhy Shares of Ambrx Biopharma Jumped This WeekThe company reported data on its clinical programs at two conferences this week.
May 18, 2023 by James HalleyWhy Shares of NanoString Technologies Are Falling ThursdayThe company lost a patent ruling in Germany to life sciences competitor 10x Genomics.
May 17, 2023 by James HalleyWhy Shares of Bausch Health Soared WednesdayThe company won a big patent fight with a generic-drug maker.
May 17, 2023 by James HalleyWhy P3 Healthcare Shares Jumped WednesdayThe company's CEO showed confidence with a big stock buy.
May 17, 2023 by James HalleyReady to Buy the Dip? This Biotech Stock Is a Smart BuyThe company's expertise with messenger RNA technology is widely applicable in healthcare.
May 16, 2023 by James HalleyWhy Shares of Summit Therapeutics Slumped on TuesdayThe company's shares have been falling since it announced earnings late last week.
May 16, 2023 by James HalleyWhy Shares of Savara Jumped on TuesdayThe company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.
May 16, 2023 by James HalleyWhich Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?Both stocks have built-in economic diversity and are solid long-term investments.
May 15, 2023 by James HalleyWhy Shares of Denali Therapeutics Are Up MondayAnalysts maintained their buy ratings on the clinical-stage biotech company.
May 15, 2023 by James HalleyWhy Shares of Point Biopharma Global Rose MondayThe company made a deal to help speed its clinical trials along.
